Loading patent…
AssigneeTasly Pharmaceutical Group Co., Ltd.
InventorsHe Sun, Kaijing Yan, Xiaohui Ma, Shunnan Zhang, Yi He, Haoshu Xiong, Yongfeng Zheng, Xinxin Li, Hongbo Zhang, Yanmei Li, Jing Wang, Tiantian Wen, Zhipeng Huo, Lijun Fan, Wei Sun, Jianchun Wang, Nan Cai, Rui Yang, Jingjing Zhang
Estimating the term…
The present invention provides a pharmaceutical composition for treating myocardial ischemia, comprising Salvia Miltiorrhiza medicinal material 250-700 parts by weight, Radix Notoginseng medicinal material 50-150 parts by weight, Borneolum Syntheticum 3-9 parts by weight, and ranolazine 25-100 parts by weight. According to a further aspect of the present invention, there is provided a use of a pharmaceutical composition for preparation of a medicine for prevention and/or treatment of myocardial ischemia.
A pharmaceutical composition for treating myocardial ischemia, comprising Salvia miltiorrhiza medicinal material in an amount of 250-700 parts by weight, Radix Notoginseng medicinal material in an amount of 50-150 parts by weight, Borneolum Syntheticum in an amount of 3-9 parts by weight, and ranolazine in an amount of 25-100 parts by weight.
Dependencies are inferred from the claim text.